Saraf & Partners, and Jerome Merchant + Partners have advised on 360 ONE Alternates Asset Management’s investment in House of Diagnostics Healthcare for an undisclosed amount and stake.
House of Diagnostics has struck definitive agreements with 360 ONE Alternates Asset Management, acting as investment manager for 360 ONE investment schemes, for a minority stake in the company. The transaction comprises a combination of primary and secondary investments.
Saraf & Partners counselled House of Diagnostics and its promoter group, advising on all aspects of the transaction, including structuring, legal due diligence, drafting, negotiation and finalisation of the definitive agreements.
Senior partner Vaibhav Kakkar and partners Sahil Arora and Debarpan Ghosh led the transaction team, with the assistance of senior associate Paayas Pandit, as well as associates Ishaan Gupta, Samiksha Bhargava, Krishna Lohia and Suraj Kumar. Arora and Ghosh also led the due diligence team, with assistance from their associates.
Jerome Merchant + Partners advised the 360 ONE team.
House of Diagnostics plans to deploy the capital to expand into Mumbai and other larger markets such as Hyderabad and Bengaluru, targeting digitally savvy patients who value transparent pricing and high-quality, technology-enabled care.
House of Diagnostics is a leading provider of integrated diagnostics and imaging services in North India. 360 ONE is a leading Indian alternative investment firm specialising in private equity, private credit and real assets.
